4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow IW-1973: new trials by email Literature Review of IW-1973 trials Research Report on IW-1973
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) IW-1973, Placebo Oral Tablet - Heart Failure With Preserved Ejection Fraction | Phase 2 | Completed | Akebia Therapeutics | 196 | 2017-11-07 | 2022-09-15 |
| A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria IW-1973, Placebo - Type 2 Diabetes Mellitus With Diabetic Nephropathy | Phase 2 | Completed | Akebia Therapeutics | 156 | 2017-08-01 | 2022-09-15 |
| Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension IW-1973, Placebo - Diabetes Mellitus, Type 2, Hypertension | Phase 2 | Completed | Cyclerion Therapeutics | 26 | 2017-02-28 | 2020-08-31 |
| A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension Matching Placebo, IW-1973 - Diabetes Mellitus, Type 2, Hypertension | Phase 2 | Completed | Cyclerion Therapeutics | 11 | 2016-09-01 | 2020-04-16 |
Diabetes Mellitus, Type 2 (2) · Hypertension (2) · Heart Failure (1)
Akebia Therapeutics (2) · Cyclerion Therapeutics (2)
United States (4) · Canada (1)
Jelena Seferovic, MD PhD (1) · John Hanrahan, MD MPH (1)
PMID 31858186, PMID 32105984, PMID 33079154, PMID 33328269, PMID 39833553